Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil
NCT01171157 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2018-06-01
Summary
The purpose of this research study is to estimate how many elderly people who have symptoms that look like influenza (i.e. an influenza-like illness) actually have the disease and how effective influenza vaccines are in preventing influenza in elderly people. The study will also examine the severity of the disease (e.g. how long are people ill, were there any complications) and how it affects everyday life (e.g. cost, medications, care by family members).
Conditions
Interventions
- OTHER
-
Routine sample collection
Collection of routine nasal/throat swab samples
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-26
- Primary Completion
- 2009-06-01
- Completion
- 2009-06-29
Countries
- Brazil
More Related Trials
-
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older
NCT00760617 ·Status: COMPLETED ·Phase: PHASE3
-
The Immune Response to Influenza Vaccinations in Elderly Individuals
NCT03266237 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .
NCT05779020 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
NCT00992784 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects
NCT01459276 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00342940 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
NCT01265914 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
NCT02876159 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine
NCT00866580 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects
NCT01161264 ·Status: COMPLETED ·Phase: PHASE3
-
Inactivated Influenza A/H5N1 Vaccine in the Elderly
NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
NCT03315104 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
NCT02313740 ·Status: COMPLETED
-
Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB
NCT02819180 ·Status: COMPLETED
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
NCT03657719 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
NCT00753272 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Immunization in Adults Over Age 75
NCT02200276 ·Status: RECRUITING ·Phase: NA
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
NCT02247362 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2